Non-Profit Answers Questions About New Drug Aimed At Treating Nausea And Vomiting In Pregnancy

Experts Say The Drug May Help Curb Some Pregnancy ComplicationsBrentwood, TN – As the U.S. Food and Drug Administration (FDA) announces approval of Diclegis (docylamine succinate and pyridoxine hydrochloride) to treat nausea and vomiting in pregnancy (NVP), MotherToBaby experts have begun fielding questions about the much-debated drug’s risks to a woman’s developing baby. Experts at MotherToBaby, the counseling service branch of the non-profit Organization of Teratology Information Specialists (OTIS), said NVP affects nearly 80% of pregnant women, usually in their first trimester. A